1233955-69-5

Basic information

• Product Name: tert-butyl 4-[(methylcarbamoyl)amino]piperidine-1-carboxylate
• CAS NO: 1233955-69-5
• Molecular Weight: 257.333
• Mol File: 1233955-69-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: tert-butyl 4-[(methylcarbamoyl)amino]piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-[(methylcarbamoyl)amino]piperidine-1-carboxylate(1233955-69-5)
• EPA Substance Registry System: tert-butyl 4-[(methylcarbamoyl)amino]piperidine-1-carboxylate(1233955-69-5)

Safety Data

• Hazardous Substances Data: 1233955-69-5(Hazardous Substances Data)

Upstream product

• 74-89-5 methylamine 
• 87120-72-7 1-(tert-butoxycarbonyl)-4-aminopiperidine 
• 6452-47-7 methylcarbamoyl chloride 
• 670253-16-4 4-[(phenoxycarbonyl)amino]piperidine-1-carboxylic acid tert-butyl ester 
• 180695-80-1 tert-butyl 4-azidopiperidine-1-carboxylate 
• 180695-79-8 tert-butyl 4-bromo-1-piperidinecarboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 90633-18-4 4-bromo-1H-piperidine 
• 624-83-9 methyl isocyanate 

Relevant articles and documents

Discovery of SHR0687, a Highly Potent and Peripheral Nervous System-Restricted KOR Agonist

Analgesics with no abuse liability are highly demanded in the market. KOR agonists have been proved to be strong analgesics without MOR agonist-related side effects, such as respiratory depression, tolerance, and dependence liability; however, activation

Phenyl-propionamide derivative, and preparation method and application thereof in medicine

The invention relates to a phenyl-propionamide derivative, and a preparation method and application thereof in medicine, in particular to a phenyl-propionamide derivative shown in a general formula (I), a preparation method thereof and a medicine composition comprising the derivative, a use as a k opioid receptor (KOR receptor) agonist, and an application in preparing drugs for treating and/or preventing pains and pain-related diseases. The definition of various substituent groups of the general formula (I) is same with the definition in the description. The formula is shown in the description.

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: Synthesis and structure-activity relationships for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N- (benzyloxycarbonyl)amino)piperidin-1-yl)butanes

(2S)-2-(3-Chlorophenyl)-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-[spiro (2,3-dihydrobenzthiophene-3,4′-piperidin-1′-yl)]butane S-oxide (1b) has been identified as a potent CCR5 antagonist having an IC50 = 10 nM. Herein, structure-activity relationship studies of non-spiro piperidines are described, which led to the discovery of 4-(N-(alkyl)-N-(benzyloxycarbonyl)amino)piperidine derivatives (3-5) as potent CCR5 antagonists.